
|Articles|May 16, 2020
ASCRS 2020: Updates, improved injection technique from Eyepoint Pharmaceuticals
Author(s)Alex Delaney-Gesing
Advertisement
Ophthalmology Times' Sheryl Stevenson speaks with Eyepoint Pharmaceuticals' President/CEO Nancy Lurker and Chief Medical Officer Dario Paggiarino, MD, on the company's latest developments and research ahead of the ASCRS 2020 virtual meeting.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR Surgical terminates proposed acquisition by Alcon
2
Innovations in glaucoma poised for breakthrough in 2026 (and what might hold them back)
3
Rates of retinal layer thinning predict visual field progression in glaucoma
4
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
5












































